AGRX Agile Therapeutics Stock Forecast Period (n+1y) 22 Dec 2020


Stock Forecast


As of Tue Dec 22 2020 21:58:25 GMT+0000 (Coordinated Universal Time) shares of AGRX Agile Therapeutics 0.85 percentage change in price since the previous day's close. Around 538552 of 87435000 changed hand on the market. The Stock opened at 2.95 with high and low of 2.88 and 2.97 respectively. The price/earnings ratio is: - and earning per share is -0.5. The stock quoted a 52 week high and low of 1.35 and 4.77 respectively.

BOSTON (AI Forecast Terminal) Tue, Dec 22, '20 AI Forecast today took the forecast actions: In the context of stock price realization of AGRX Agile Therapeutics is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+1y) for AGRX Agile Therapeutics as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of AGRX Agile Therapeutics as below:

AGRX Agile Therapeutics Credit Rating Overview


We rerate AGRX Agile Therapeutics because of the level of the two metrics relative to the entity's credit and market risks. We use econometric methods for period (n+1y) simulate with Colpitts Oscillator Logistic Regression. Reference code is: 3535. Beta DRL value REG 42 Rational Demand Factor LD 5059.1226. For new issuers, while our ratings are prospective, we will not include proposed financing as a source in our liquidity calculations until the financing has been obtained or is fully underwritten. Similarly, we would not include rights issues as a source of liquidity for a company, unless the rights issue is irrevocably guaranteed (for example, an underwriter agrees to buy any securities not taken up by existing holders). Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for AGRX Agile Therapeutics as below:
Frequently Asked QuestionsQ: What is AGRX Agile Therapeutics stock symbol?
A: AGRX Agile Therapeutics stock referred as NASDAQ:AGRX
Q: What is AGRX Agile Therapeutics stock price?
A: On share of AGRX Agile Therapeutics stock can currently be purchased for approximately 2.96
Q: Do analysts recommend investors buy shares of AGRX Agile Therapeutics ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for AGRX Agile Therapeutics at daily forecast section
Q: What is the earning per share of AGRX Agile Therapeutics ?
A: The earning per share of AGRX Agile Therapeutics is -0.5
Q: What is the market capitalization of AGRX Agile Therapeutics ?
A: The market capitalization of AGRX Agile Therapeutics is 258369236
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. All data and information is provided “as is” for personal informational purposes only, and is not intended for trading purposes or advice. Please consult your broker or financial representative to verify pricing before executing any trade.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com